The influence of antineoplastic treatment on the weight of survivors of childhood cancer
Author(s) -
Julia Ferrari Carneiro Teixeira,
Priscila Dos Santos Maia-Lemos,
Mônica Cypriano,
Luciana Pellegrini Pisani
Publication year - 2016
Publication title -
jornal de pediatria
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.645
H-Index - 52
eISSN - 1678-4782
pISSN - 0021-7557
DOI - 10.1016/j.jped.2016.04.003
Subject(s) - medicine , obesity , cancer , childhood leukemia , total body irradiation , population , disease , leukemia , leptin , radiation therapy , oncology , pediatrics , chemotherapy , lymphoblastic leukemia , environmental health , cyclophosphamide
Obesity is a late effect in survivors of childhood cancer and correlates with chronic complications. Survivors of leukemia, brain tumors, and hematopoietic stem cell transplantation are more likely to develop obesity resulting from treatment modalities such as radiotherapy and glucocorticoids. This paper analyzes and integrates the current data available to health professionals in order to clarify strategies that can be used to treat and prevent obesity in childhood cancer survivors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom